Key facts
- Eko (Monitoring Equipment)’s last known valuation is $278.0M.
- It has raised $162.1M; the latest was Later Stage VC ($40.0M) in Jun 2024.
- Notable investors include MedTech Innovator, Gaingels, Peak XV Partners, National Institutes of Health, StartX (US) — 50 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 50 names
- ·Watchlist + deal alerts for Eko (Monitoring Equipment)
- ·The full record, as it builds
Funding rounds
No funding rounds for Eko (Monitoring Equipment) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Eko (Monitoring Equipment)
Developer of an artificial intelligence-powered digital stethoscope designed to aid heart and lung disease detection. The company's digital stethoscopes eliminate distracting background noise with amplification and provide analysis for improved diagnosis and patient care, enabling healthcare professionals to visualize, record, and share patient data with greater accuracy.
- Sector
- Healthcare
- HQ
- Emeryville, CA, United States
- Founded
- 2013
- Employees
- 180
- Website
- ekohealth.com/
- Ownership
- Privately Held (backing)
Eko (Monitoring Equipment) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Eko (Monitoring Equipment) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Eko (Monitoring Equipment) in its N-PORT filings yet. We sweep new filings monthly.